Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Maejima

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
European Journal of Hybrid Imaging|June 30, 2021
Takayasu arteritis: clinical importance of extra-vessel uptake on FDG PET/CTJunichi Tsuchiya, Daisuke Tezuka, Yasuhiro Maejima, et al.
Cardiovascular Research|June 15, 2004
Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injuryYasuyuki Onai, Jun-Ichi Suzuki, Tsunekazu Kakuta, et al.
JACC. Basic to Translational Science|July 5, 2021
Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune MyocarditisYuka Shiheido-Watanabe, Yasuhiro Maejima, Takeshi Kasama, et al.
Journal of Cardiology|October 18, 2015
Suppression of murine autoimmune myocarditis achieved with direct renin inhibitionChisato Takamura, Jun-Ichi Suzuki, Masahito Ogawa, et al.
Journal of Molecular and Cellular Cardiology|February 24, 2009
Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathwayTakaaki Haga, Jun-Ichi Suzuki, Hisanori Kosuge, et al.
International Heart Journal|March 25, 2008
Blockade of the 4-1BB pathway attenuates graft arterial disease in cardiac allograftsHitoshi Saiki, Jun-Ichi Suzuki, Hisanori Kosuge, et al.
Life Sciences|May 23, 2006
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1Kino Morikawa-Futamatsu, Susumu Adachi, Yasuhiro Maejima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 30, 2005
Exercise after heparin administration: new therapeutic program for patients with-option arteriosclerosis oblitransYasuhiro Maejima, Takanori Yasu, Hiroto Ueba, et al.
Cardiovascular Research|January 31, 2026
Cardiomyocyte-specific deficiency of C/EBPβ aggravates pressure overload-induced heart failureJihoon Nah, Eun-Ah Sung, Peiyong Zhai, et al.
Frontiers in Medicine|May 22, 2023
Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitidesNatsuka Umezawa, Fumitaka Mizoguchi, Yasuhiro Maejima, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
European Journal of Hybrid Imaging|June 30, 2021
Takayasu arteritis: clinical importance of extra-vessel uptake on FDG PET/CTJunichi Tsuchiya, Daisuke Tezuka, Yasuhiro Maejima, et al.
Cardiovascular Research|June 15, 2004
Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injuryYasuyuki Onai, Jun-Ichi Suzuki, Tsunekazu Kakuta, et al.
JACC. Basic to Translational Science|July 5, 2021
Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune MyocarditisYuka Shiheido-Watanabe, Yasuhiro Maejima, Takeshi Kasama, et al.
Journal of Cardiology|October 18, 2015
Suppression of murine autoimmune myocarditis achieved with direct renin inhibitionChisato Takamura, Jun-Ichi Suzuki, Masahito Ogawa, et al.
Journal of Molecular and Cellular Cardiology|February 24, 2009
Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathwayTakaaki Haga, Jun-Ichi Suzuki, Hisanori Kosuge, et al.
International Heart Journal|March 25, 2008
Blockade of the 4-1BB pathway attenuates graft arterial disease in cardiac allograftsHitoshi Saiki, Jun-Ichi Suzuki, Hisanori Kosuge, et al.
Life Sciences|May 23, 2006
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1Kino Morikawa-Futamatsu, Susumu Adachi, Yasuhiro Maejima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 30, 2005
Exercise after heparin administration: new therapeutic program for patients with-option arteriosclerosis oblitransYasuhiro Maejima, Takanori Yasu, Hiroto Ueba, et al.
Cardiovascular Research|January 31, 2026
Cardiomyocyte-specific deficiency of C/EBPβ aggravates pressure overload-induced heart failureJihoon Nah, Eun-Ah Sung, Peiyong Zhai, et al.
Frontiers in Medicine|May 22, 2023
Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitidesNatsuka Umezawa, Fumitaka Mizoguchi, Yasuhiro Maejima, et al.
Pageof 13